Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annalisa Iezzi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|June 23, 2007
COX-2: friend or foe?Annalisa Iezzi, Claudio Ferri, Andrea Mezzetti, et al.
Gastrointestinal Endoscopy|August 4, 2015
Agreement of site and central readings of ileocolonoscopic scores in Crohn's disease: comparison using data from the EXTEND trialPaul Rutgeerts, Walter Reinisch, Jean-Frederic Colombel, et al.
Stroke|August 7, 2004
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaquesFrancesco Cipollone, Maria Fazia, Gabriella Mincione, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 4, 2005
Association between 5-lipoxygenase expression and plaque instability in humansFrancesco Cipollone, Andrea Mezzetti, Maria Luigia Fazia, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 25, 2004
Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humansFrancesco Cipollone, Maria Fazia, Annalisa Iezzi, et al.
Circulation|November 19, 2003
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplastyFrancesco Cipollone, Claudio Ferri, Giovambattista Desideri, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in humanFrancesco Cipollone, Maria Luigia Fazia, Annalisa Iezzi, et al.
Diabetes Care|September 28, 2002
Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetesFrancesco Chiarelli, Francesco Cipollone, Angelika Mohn, et al.
Circulation|August 13, 2003
The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic controlFrancesco Cipollone, Annalisa Iezzi, Maria Fazia, et al.
Circulation|March 24, 2004
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activityFrancesco Cipollone, Maria Fazia, Annalisa Iezzi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|June 23, 2007
COX-2: friend or foe?Annalisa Iezzi, Claudio Ferri, Andrea Mezzetti, et al.
Gastrointestinal Endoscopy|August 4, 2015
Agreement of site and central readings of ileocolonoscopic scores in Crohn's disease: comparison using data from the EXTEND trialPaul Rutgeerts, Walter Reinisch, Jean-Frederic Colombel, et al.
Stroke|August 7, 2004
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaquesFrancesco Cipollone, Maria Fazia, Gabriella Mincione, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 4, 2005
Association between 5-lipoxygenase expression and plaque instability in humansFrancesco Cipollone, Andrea Mezzetti, Maria Luigia Fazia, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 25, 2004
Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humansFrancesco Cipollone, Maria Fazia, Annalisa Iezzi, et al.
Circulation|November 19, 2003
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplastyFrancesco Cipollone, Claudio Ferri, Giovambattista Desideri, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in humanFrancesco Cipollone, Maria Luigia Fazia, Annalisa Iezzi, et al.
Diabetes Care|September 28, 2002
Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetesFrancesco Chiarelli, Francesco Cipollone, Angelika Mohn, et al.
Circulation|August 13, 2003
The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic controlFrancesco Cipollone, Annalisa Iezzi, Maria Fazia, et al.
Circulation|March 24, 2004
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activityFrancesco Cipollone, Maria Fazia, Annalisa Iezzi, et al.
Pageof 2